Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Am J Dermatopathol. 2017 Oct;39(10):731–737. doi: 10.1097/DAD.0000000000000780

Figure 3.

Figure 3

Quantitative MIA-based assessment of c-CBL expression across the spectrum of secondary lymphoid tissue (reactive tonsil tissue, 5 cases), BIDs (47 cases), CTCL lesional skin (18 cases) and CTCL cell lines (5 distinct cell lines). * p < 0.05 as compared to tonsil, ** p < 0.05 as compared to tonsil as well as BIDs, *** p < 0.05 as compared to tonsil, BIDs and CTCL lesions.